Ropes & Gray has advised Chiesi Farmaceutici S.p.A. Kirkland & Ellis and Fenwick & West have advised KalVista Pharmaceuticals, Inc. Chiesi Farmaceutici S.p.A., an international biopharmaceutical...
Chiesi to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal
Zymeworks to Acquire Theravance Biopharma in $929 Million Transaction
Skadden has advised Theravance Biopharma. Kirkland & Ellis and Matheson have advised Zymeworks. Theravance Biopharma, Inc. and Zymeworks Inc. have entered into a definitive agreement under...
Angelini Pharma Acquires Catalyst Pharmaceuticals in $4.1 Billion Deal
Hogan Lovells, Gatti Pavesi Bianchi Ludovici, and Maisto e Associati have advised Angelini Pharma. Linklaters has advised BNP Paribas. Legance has advised Blackstone. Kirkland & Ellis...
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion
Jones Day has advised BioMarin Pharmaceutical Inc. in the acquisition of Amicus Therapeutics. Kirkland & Ellis has advised Amicus Therapeutics. BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has...
Tokio Marine Acquires Agrihedge for $970 Million
Kirkland & Ellis has advised Tokio Marine Holdings, Inc. Falfurrias Capital Partners and Commodity & Ingredient Hedging were served by William Blair and K&L Gates LLP....
Novartis Acquires Avidity Biosciences in USD 12 Billion Transaction and Completes USD 11 Billion Financing
Covington and Homburger have advised Novartis. Kirkland & Ellis and Wilson Sonsini Goodrich & Rosati have advised Avidity Biosciences. Linklaters has advised a global underwriting syndicate....
Novo Nordisk to Acquire Akero Therapeutics for Up to $5.2 Billion
Ropes & Gray has advised Novo Nordisk, and Kirkland & Ellis has advised Akero Therapeutics. Novo Nordisk has entered into a definitive agreement to acquire Akero...
XenoTherapeutics to Acquire ESSA Pharma in All-Cash Agreement Backed by XOMA Royalty
Skadden, Arps, Slate, Meagher & Flom LLP, alongside Blake, Cassels & Graydon LLP, have advised ESSA Pharma Inc. Stikeman Elliott LLP and Gibson, Dunn & Crutcher...
Alcon Announces Acquisition of LumiThera and Photobiomodulation Device for Dry AMD
Skadden has advised Alcon. Alcon has announced its intention to acquire LumiThera, Inc., a company recognized for its light-based innovations in ophthalmology, along with its photobiomodulation...
Jazz Pharmaceuticals’ $935 Million Acquisition of Chimerix
Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Jazz, while Skadden and Cooley are advising Chimerix on the deal. Jazz Pharmaceuticals plc and...
Emerson’s $7.2 Billion Acquisition of Remaining Outstanding Shares of AspenTech
Davis Polk & Wardwell is serving as legal advisor to Emerson, while Skadden, Arps, Slate, Meagher & Flom is serving as legal counsel to the AspenTech...
TowerBrook and CD&R’s $8.9 Billion Acquisition R1 RCM
Kirkland & Ellis is advising R1 RCM, Skadden is advising a special committee of the R1 RCM Inc. in the transaction, while Wachtell, Lipton, Rosen &...